Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 318.51M | 486.64M | 417.04M | 156.59M | 254.63M | 468.24M |
Gross Profit | 33.70M | 43.95M | 43.58M | 33.16M | -38.46M | 43.52M |
EBITDA | 14.46M | 17.43M | 10.82M | -5.10M | -25.85M | 59.42M |
Net Income | 7.56M | 8.27M | 2.39M | -24.56M | -51.51M | 23.73M |
Balance Sheet | ||||||
Total Assets | 309.47M | 308.42M | 338.93M | 335.19M | 405.05M | 576.57M |
Cash, Cash Equivalents and Short-Term Investments | 34.14M | 39.48M | 18.63M | 25.48M | 14.61M | 22.57M |
Total Debt | 8.96M | 8.78M | 11.02M | 23.29M | 93.05M | 165.70M |
Total Liabilities | 36.56M | 41.93M | 80.71M | 79.36M | 144.02M | 264.03M |
Stockholders Equity | 272.91M | 266.49M | 258.22M | 255.83M | 261.03M | 312.54M |
Cash Flow | ||||||
Free Cash Flow | 29.80M | 38.50M | -17.77M | 29.14M | 60.63M | 6.87M |
Operating Cash Flow | 31.03M | 39.72M | -14.51M | 34.44M | 61.67M | 26.75M |
Investing Cash Flow | -1.43M | -19.83M | 22.89M | 30.29M | 10.78M | -18.83M |
Financing Cash Flow | -2.73M | -2.89M | -15.22M | -53.87M | -80.41M | -6.75M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
70 Outperform | $16.83B | 8.16 | 16.66% | 5.53% | -8.19% | -9.98% | |
58 Neutral | HK$13.89B | 4.44 | -3.01% | 7.32% | 3.67% | -54.16% | |
57 Neutral | HK$74.34M | 15.35 | 1.80% | ― | -46.10% | -38.04% | |
45 Neutral | HK$74.80M | ― | -102.44% | ― | -24.20% | -97.97% | |
40 Underperform | HK$91.01M | 68.18 | -21.90% | ― | -8.34% | -8828.57% | |
31 Underperform | $142.20M | ― | ― | -69.69% | -9.41% |